Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Common Equity
We only have one class of common stock. Our common stock is listed on the New York Stock Exchange under the symbol “RVTY”. As of February 21, 2025, we had approximately 2,753 holders of record of our common stock .
Stock Repurchases and Dividends
The following table provides information with respect to the shares of common stock repurchased by us for the periods indicated.
Issuer Repurchases of Equity Securities
Period Total Number
of Shares
Purchased (1)
Average Price
Paid Per
Share Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs (2)
Maximum Aggregate Number (or Approximate Dollar Value) of Shares that May Yet
Be Purchased
Under the Plans or
Programs
September 30, 2024 - October 27, 2024
351,461 $ 120.54 30,000 $ 996,456,502
October 28, 2024 - November 24, 2024
537,773 115.16 537,705 934,536,467
November 25, 2024 - December 29, 2024
671,949 115.23 671,050 857,209,712
Activity for quarter ended December 29, 2024
1,561,183 $ 116.40 1,238,755 $ 857,209,712
________________
(1) Our Board of Directors (our “Board”) has authorized us to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to our equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to our equity incentive plans. During the fourth quarter of fiscal year 2024, we repurchased 37,443 shares of common stock for this purpose at an aggregate cost of $4.6 million. The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value.
(2) On April 27, 2023, our Board authorized us to repurchase shares of common stock for an aggregate amount up to $600.0 million under a stock repurchase program (the “Repurchase Program”). On October 24, 2024, the Repurchase Program was terminated by our Board and our Board authorized us to repurchase shares of common stock for an aggregate amount up to $1.0 billion under a new stock repurchase program (the “New Repurchase Program”). No shares remain available for repurchase under the Repurchase Program due to its termination. The New Repurchase Program will expire on October 23, 2026, unless terminated earlier by our Board and may be suspended or discontinued at any time. During fiscal year 2024 , we repurchased 1,820,296 shares of common stock under the Repurchase Program for an aggregate cost of $213.6 million. During the fourth quarter of fiscal year 2024 , we repurchased 284,985 shares of common stock under the Repurchase Program for an aggregate cost of $34.3 million . During the fourth quarter of fiscal year 2024 , we repurchased 1,238,755 shares of common stock under the New Repurchase Program for an aggregate cost of $142.8 million . As of December 29, 2024, $857.2 million remained available for aggregate repurchases of shares under the New Repurchase Program.
Our Board of Directors declared a cash dividend of $0.07 per share during the fourth quarter of fiscal year 2024 that was paid in February 2025. Refer to Note 17, Stockholders' Equity, in the Notes to Consolidated Financial Statements for further discussion regarding stock repurchases and dividends.
26
Table of Contents
Stock Performance Graph
Set forth below is a line graph comparing the cumulative total shareholder return on our common stock against the cumulative total return of the S&P Composite-500 Index and the S&P 500 Life Sciences Tools & Services Industry Index for the five fiscal years from December 29, 2019 to December 29, 2024.
Comparison of Five-Year Cumulative Total Return
Among Revvity, Inc. Common Stock, S&P Composite-500 and
S&P 500 Life Sciences Tools & Services Industry Index
TOTAL RETURN TO SHAREHOLDERS
(Includes reinvestment of dividends)
12/29/2019 1/3/2021 1/2/2022 1/1/2023 12/31/2023 12/29/2024
Revvity, Inc. $ 100.00 $ 148.27 $ 208.13 $ 145.42 $ 113.62 $ 116.71
S&P 500 Index $ 100.00 $ 118.40 $ 152.39 $ 124.79 $ 157.59 $ 197.02
S&P 500 Life Sciences Tools & Services Industry Index $ 100.00 $ 133.01 $ 184.53 $ 142.26 $ 137.88 $ 133.07
Item 6. [Reserved]
Reserved.
27
Table of Contents